STAT

STAT+: Pharmalittle: Novavax faces raw-materials shortages for Covid-19 shot; India curbs vaccine exports

Novavax is delaying signing a contract to supply its Covid-19 vaccine to the European Union because the company is struggling to source raw materials.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall,

Estás leyendo una vista previa, regístrate para leer más.

Más de STAT

STAT1 min. leídosMedical
STAT+: Pharmalittle: Feds Sue Walmart Over Opioid Prescriptions; U.S. Buys More Pfizer Vaccine Doses
According to a 160-page civil complaint, Walmart knew its system for detecting suspicious prescriptions was faulty but did little to address the matter as its network of pharmacies filled millions…
STAT1 min. leídosMedical
STAT+: Pharmalittle: J&J Seeks Emergency Use For Its Coronavirus Vaccine; Merck Says Parasite Drug Does Not Work On Covid-19
Johnson & Johnson has applied to the FDA for an emergency use authorization for its one-dose Covid-19 vaccine, setting in motion a process all but sure to see a third…
STAT1 min. leídosMedical
STAT+: Pharmalittle: Single Pfizer Shot Is 85% Effective In Preventing Symptomatic Covid-19; Biden To Commit $4 Billion To COVAX
An Israeli study found that a single shot of the Covid-19 vaccine from Pfizer (PFE) and BioNTech (BNTX) is 85% effective in preventing symptomatic disease.